Proctor, M.; Gonzalez Cruz, J.L.; Daignault-Mill, S.M.; Veitch, M.; Zeng, B.; Ehmann, A.; Sabdia, M.; Snell, C.; Keane, C.; Dolcetti, R.;
et al. Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers 2021, 13, 3733.
https://doi.org/10.3390/cancers13153733
AMA Style
Proctor M, Gonzalez Cruz JL, Daignault-Mill SM, Veitch M, Zeng B, Ehmann A, Sabdia M, Snell C, Keane C, Dolcetti R,
et al. Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers. 2021; 13(15):3733.
https://doi.org/10.3390/cancers13153733
Chicago/Turabian Style
Proctor, Martina, Jazmina L. Gonzalez Cruz, Sheena M. Daignault-Mill, Margaret Veitch, Bijun Zeng, Anna Ehmann, Muhammed Sabdia, Cameron Snell, Colm Keane, Riccardo Dolcetti,
and et al. 2021. "Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression" Cancers 13, no. 15: 3733.
https://doi.org/10.3390/cancers13153733
APA Style
Proctor, M., Gonzalez Cruz, J. L., Daignault-Mill, S. M., Veitch, M., Zeng, B., Ehmann, A., Sabdia, M., Snell, C., Keane, C., Dolcetti, R., Haass, N. K., Wells, J. W., & Gabrielli, B.
(2021). Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers, 13(15), 3733.
https://doi.org/10.3390/cancers13153733